[HTML][HTML] Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers
Chemical and enzymatic barriers in the gastrointestinal (GI) tract hamper the oral delivery of
many labile drugs. The GI epithelium also contributes to poor permeability for numerous …
many labile drugs. The GI epithelium also contributes to poor permeability for numerous …
Structured edible lipid-based particle systems for oral drug-delivery
Oral administration is the most popular and patient-compliant route for drug delivery, though
it raises great challenges due to the involvement of the gastro-intestine (GI) system and the …
it raises great challenges due to the involvement of the gastro-intestine (GI) system and the …
Synthesis, structure and characterization of new dithiocarbazate-based mixed ligand oxidovanadium (IV) complexes: DNA/HSA interaction, cytotoxic activity and DFT …
A Banerjee, M Mohanty, S Lima, R Samanta… - New Journal of …, 2020 - pubs.rsc.org
Three new mixed-ligand oxidovanadium (IV) complexes [VIVOL1–2 (LN–N)](1–3) have
been synthesized using two tridentate bi-negative–ONS chelating dithiocarbazate ligands …
been synthesized using two tridentate bi-negative–ONS chelating dithiocarbazate ligands …
Nanotechnology-based strategies in parasitic disease management: from prevention to diagnosis and treatment
Parasitic infections are a major global health issue causing significant mortality and
morbidity. Despite substantial advances in the diagnostics and treatment of these diseases …
morbidity. Despite substantial advances in the diagnostics and treatment of these diseases …
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
The study of neglected diseases has not received much attention, especially from public and
private institutions over the last years, in terms of strong support for developing treatment for …
private institutions over the last years, in terms of strong support for developing treatment for …
From Benznidazole to new drugs: Nanotechnology contribution in Chagas disease
DC Gomes, TS Medeiros, EL Alves Pereira… - International Journal of …, 2023 - mdpi.com
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …
Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
Abstract Neglected Tropical Diseases (NTDs) comprise of a group of seventeen infectious
conditions endemic in many developing countries. Among these diseases are three of …
conditions endemic in many developing countries. Among these diseases are three of …
Dithiocarbazate based oxidomethoxidovanadium (V) and mixed-ligand oxidovanadium (IV) complexes: Study of solution behavior, DNA binding, and anticancer …
In this work, one oxidomethoxidovanadium (V)[VVO (L)(OMe)](1) and two mixed-ligand
oxidovanadium (IV)[V IV O (L)(phen)](2), and [V IV O (L)(bipy)](3) complexes have been …
oxidovanadium (IV)[V IV O (L)(phen)](2), and [V IV O (L)(bipy)](3) complexes have been …
Nano based approach for the treatment of neglected tropical diseases
Neglected tropical diseases (NTDs) afflict more than one billion peoples in the world's
poorest countries. The World Health Organization (WHO) has recorded seventeen NTDs in …
poorest countries. The World Health Organization (WHO) has recorded seventeen NTDs in …
Advances in nanocarriers as drug delivery systems in Chagas disease
C Quijia Quezada, CS Azevedo… - International journal …, 2019 - Taylor & Francis
Chagas disease is one of the most important public health problems in Latin America due to
its high mortality and morbidity levels. There is no effective treatment for this disease since …
its high mortality and morbidity levels. There is no effective treatment for this disease since …